The use of vacuolar ATPase inhibitors in the prevention and/or treatment of inflammatory and autoimmune diseases is herein described. Vacuolar ATPase inhibitors are selected among products of natural, semi-synthetic or synthetic origin; more preferred are inhibitors based on a 2- and/or 3-substituted indole, azaindole or benzimidazole structure.

V-Atpase Inhibitors of Use in the Treatment of Septic Shock / C. Farina, G. Constantin, C. Laudanna, P. Misiano.

V-Atpase Inhibitors of Use in the Treatment of Septic Shock

P. Misiano
Primo
2007

Abstract

The use of vacuolar ATPase inhibitors in the prevention and/or treatment of inflammatory and autoimmune diseases is herein described. Vacuolar ATPase inhibitors are selected among products of natural, semi-synthetic or synthetic origin; more preferred are inhibitors based on a 2- and/or 3-substituted indole, azaindole or benzimidazole structure.
NiKem Research S.r.l
WO2007/048848
PCT/EP2006/067890
Settore CHIM/08 - Chimica Farmaceutica
Settore MED/04 - Patologia Generale
V-Atpase Inhibitors of Use in the Treatment of Septic Shock / C. Farina, G. Constantin, C. Laudanna, P. Misiano.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/247131
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact